Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Skin ointment for treating skin of the labia minora

A technology for labia minora and skin, applied in skin diseases, ointment delivery, medical preparations of non-active ingredients, etc., can solve the problems of increasing female cancer incidence and side effects, and achieve the effect of improving wound healing effect

Pending Publication Date: 2019-09-17
BENEV BIO LAB CO
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In addition, the biggest problem with estrogen therapeutic preparations is the increase in the incidence of cancer in women, and there are cases of side effects caused by hormone imbalance in young women

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Skin ointment for treating skin of the labia minora
  • Skin ointment for treating skin of the labia minora
  • Skin ointment for treating skin of the labia minora

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] Human fibroblasts (extracted from the foreskin) obtained from the Tissue Bank at University of California, Irvine, were selected for healthy, viable fibroblasts that were maintained consistently throughout all cultures The concentration of growth factors was used to prepare compound growth factors in the form of conditioned media. Prepared complex growth factors, including fibroblast growth factor (FGF), basic fibroblast growth factor (bGFG), granulocyte-macrophage colony-stimulating growth factor (GM-CSF), hepatocyte growth factor (HGF) , insulin-like growth factor 1 (IGF-1), interleukin-6, 7, 8 (IL-6, 7, 8), keratinocyte growth factor (KGF), matrix protein (Matrix proteins), platelet-derived growth factor AA (PDGF-AA), transforming growth factor beta 2 (TGF-B2), transforming growth factor beta 3 (TGF-B3), epidermal growth factor (EGF), vascular endothelial growth factor (VEGF) and tumor necrosis factor (TNF). Mixed complex growth factors, purified water, glycerin (gl...

experiment example 1

[0043] Provide skin ointment for the treatment of labia minora skin that has been prepared and put into a 15ml tube container for women who have undergone plastic surgery of the labia minora and the clitoris, and let the patient periodically apply it on the vulva once a day, and after 2 days after the operation Weekly observations.

[0044] Figure 4 It is a photo of the degree of recovery observed after applying the skin ointment for treating the skin of the labia minora according to an embodiment of the present invention to a patient who underwent plastic surgery of the labia minora and the clitoris, (a) before the operation, and (b) after the operation The photo after 2 weeks. The skin ointment for treating labia minora skin of the present invention was periodically applied once a day to the surgical site, ie, the right labia minora, and as a result, it was confirmed that significant recovery was achieved after 2 weeks.

experiment example 2

[0046] Provide skin ointment for the treatment of labia minora skin that has been prepared and put into a 15ml tube container for women who have undergone surgery due to hypertrophy of the labia minora, and let the patient periodically apply it on the vulva once a day. 20 days of observation.

[0047] Figure 5 It is a photograph of the degree of recovery observed after applying the skin ointment for treating the skin of the labia minora according to an embodiment of the present invention to a patient undergoing surgery due to hypertrophy of the labia minora. The upper part is the state before the operation, the lower part (a) is 4 days after the operation, (b) is 1 week after the operation, and (c) is 19 days after the operation. Figure 5 In (a), (b) and (c), the left labia minora is gradually recovering after being applied with hormone-containing ointment routinely prescribed after labia minora surgery (indicated by "OINT" in the photo) , the left labia minora is the degr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a skin ointment for treating skins of labia minora, and more specifically, to a skin ointment containing a multi-growth factor as an active ingredient. According to the present invention, the skin ointment for treating skins of labia minora contains a multi-growth factor as an active ingredient and is periodically applied to external genitals of a user so that the multi-growth factor induces regeneration of skin cells of the user, thereby improving a treatment effect of wound caused by vulvar vestibulitis or labia minora surgery, and solving a fundamental cause thereof. Also, according to the present invention, the skin ointment is manufactured in an ointment form while containing a multi-growth factor of a high concentration, thereby being easily applied to external genitals of a user. In addition, the skin ointment is formed without sex hormone, environmental hormone, steroid hormone, and antibiotic component, thereby not destroying hormone balance of a user and allowing a pregnant woman or a lactating woman to use the skin ointment in relief.

Description

technical field [0001] The present invention relates to a skin ointment, more specifically to a skin ointment {SKIN OINTMENT FOR TREATING SKIN OF THE LABIA MINORA} for treating labia minora skin. Background technique [0002] The labia minora refers to the thin skin located inside the labia majora in the external genitalia of the female reproductive organs. When the labia minora is too large or asymmetrical, it will bring inconvenience to daily life. In summer or in a high temperature environment, bacteria or The proliferation of fungi is more than that of ordinary people, so the incidence of vaginitis and vulvar vestibulitis is higher. In order to eliminate this inconvenience in life, in some cases, labia minora surgery can be performed. In addition to surgery for therapeutic purposes, labia minora surgery has also been performed for cosmetic purposes in recent years. [0003] figure 1 It is a schematic diagram for explaining the tendency of labia minora hypertrophy surg...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/18A61K38/30A61K38/20A61K38/19A61K9/06A61P17/00A61P15/00
CPCA61K38/1825A61K38/1833A61K38/193A61K38/30A61K38/204A61K38/2046A61K38/2053A61K38/196A61K38/1841A61K38/1808A61K38/191A61K38/1866A61K38/18A61K9/06A61K9/0014A61P17/00A61P15/00A61K2300/00A61P17/02A61K38/1858A61P15/02A61K9/0034A61K47/06A61K47/10A61K47/12A61K47/26A61K47/36A61K47/44
Inventor 徐成勋
Owner BENEV BIO LAB CO
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com